Related Experiment Video

Updated: Aug 13, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Gene therapy for carcinoma of the breast

M A Stoff-Khalili1, P Dall, D T Curiel

  • 1Division of Human Gene Therapy, Departments of Medicine, Surgery, Pathology and the Gene Therapy Center, University of Alabama at Birmingham, Birminham, AL, USA.

Cancer Gene Therapy
|January 18, 2006
PubMed

Insights

Gene therapy offers new breast cancer treatment strategies by targeting the molecular basis of the disease. Combining gene therapy with traditional treatments shows promising results for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Limited success of current breast cancer treatments necessitates novel therapeutic strategies.
  • Understanding the molecular basis of breast cancer enables targeted interventions.
  • Gene therapy presents a promising avenue for developing alternative breast cancer treatments.

Purpose of the Study:

  • To review and categorize existing gene therapy approaches for breast cancer.
  • To discuss the potential of gene therapy in clinical breast cancer treatment.
  • To highlight the progress and future prospects of gene therapy in oncology.

Main Methods:

  • Categorization of gene therapy approaches into six main types: mutation compensation, molecular chemotherapy, proapoptotic, antiangiogenic, genetic immunopotentiation, and resistance/sensitivity modulation.
  • Review of initiated clinical trials evaluating safety, toxicity, and efficacy.
  • Analysis of combined modality therapies involving gene therapy and conventional treatments.

Main Results:

  • Six distinct categories of gene therapy for breast cancer have been developed.
  • Clinical trials are underway to assess the safety and effectiveness of these approaches.
  • Combination therapies integrating gene therapy with chemotherapy or radiation demonstrate encouraging outcomes.

Conclusions:

  • Gene therapy provides a framework for developing targeted interventions in breast cancer.
  • Early clinical trials and combined modality treatments suggest significant therapeutic potential.
  • Advancements in identifying therapeutic targets and vector design are expected to enhance the role of gene therapy in breast cancer treatment.

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...